Cargando…

Distinct roles for phosphoinositide 3-kinases γ and δ in malignant B cell migration

The PI 3-kinases (PI3K) are essential mediators of chemokine receptor signaling necessary for migration of chronic lymphocytic leukemia (CLL) cells and their interaction with tissue-resident stromal cells. While the PI3Kδ-specific inhibitor idelalisib shows efficacy in treatment of CLL and other B c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Ahmed Y., Wu, Xun, Eissa, Nour, Hou, Sen, Ghia, Jean-Eric, Murooka, Thomas T., Banerji, Versha, Johnston, James B., Lin, Francis, Gibson, Spencer B., Marshall, Aaron J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127087/ https://www.ncbi.nlm.nih.gov/pubmed/29479062 http://dx.doi.org/10.1038/s41375-018-0012-5

Ejemplares similares

Ex Vivo Mitochondrial Respiration Parallels Biochemical Response to Ibrutinib in CLL Cells
por: Chowdhury, Subir Roy, et al.
Publicado: (2021)

Altered T Follicular Helper Cell Subsets and Function in Chronic Lymphocytic Leukemia
por: Wu, Xun, et al.
Publicado: (2021)

Targeting Metabolism and Autophagy in the Context of Haematologic Malignancies
por: Banerji, Versha, et al.
Publicado: (2012)

Comparison of outcome of patients with CLL who are referred or nonreferred to a specialized CLL clinic: a Canadian population‐based study
por: Beiggi, Sara, et al.
Publicado: (2016)

Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia
por: Kost, Sara E. F., et al.
Publicado: (2019)

Inhibition of phosphoinositide‑3 kinases γ/δ ameliorates pulmonary granuloma by rescuing Treg function in a sarcoidosis model
por: Zhang, Xian, et al.
Publicado: (2023)

Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry
por: Maccari, Maria Elena, et al.
Publicado: (2018)

DNA-PK hyperactivation occurs in deletion 11q chronic lymphocytic leukemia and is both a biomarker and therapeutic target for drug-resistant disease
por: Kost, Sara E. F., et al.
Publicado: (2023)

Phosphoinositide 3′-Kinase γ Facilitates Polyomavirus Infection
por: Clark, Paul, et al.
Publicado: (2020)

Loss of phosphoinositide 3-kinase γ decreases migration and activation of phagocytes but not T cell activation in antigen-induced arthritis
por: Gruen, Michael, et al.
Publicado: (2010)

The phosphoinositide-3 kinase (PI3K)-δ,γ inhibitor, duvelisib shows preclinical synergy with multiple targeted therapies in hematologic malignancies
por: Faia, Kerrie, et al.
Publicado: (2018)

Structural, Biochemical, and Biophysical Characterization of Idelalisib Binding to Phosphoinositide 3-Kinase δ
por: Somoza, John R., et al.
Publicado: (2015)

Deconvolution of bulk RNA sequencing in activated phosphoinositide 3‐kinase δ syndrome
por: Huang, Xia, et al.
Publicado: (2023)

DOCK2 and phosphoinositide-3 kinase δ mediate two complementary signaling pathways for CXCR5-dependent B cell migration
por: Wissmann, Stefanie, et al.
Publicado: (2022)

Real world risk of infusion reactions and effectiveness of front-line obinutuzumab plus chlorambucil compared with other frontline treatments for chronic lymphocytic leukemia
por: Bourrier, Nicole, et al.
Publicado: (2022)

Occurrence of B-cell lymphomas in patients with Activated Phosphoinositide 3-Kinase δ syndrome
por: Kracker, Sven, et al.
Publicado: (2014)

PPARδ Activation Acts Cooperatively with 3-Phosphoinositide-Dependent Protein Kinase-1 to Enhance Mammary Tumorigenesis
por: Pollock, Claire B., et al.
Publicado: (2011)

Lifespan of γ/δ T Cells
por: Tough, David F., et al.
Publicado: (1998)

Phosphoinositide 3-kinase δ regulates membrane fission of Golgi carriers for selective cytokine secretion
por: Low, Pei Ching, et al.
Publicado: (2010)

Case Report: First Occurrence of Plasmablastic Lymphoma in Activated Phosphoinositide 3-Kinase δ Syndrome
por: Yin, Zexi, et al.
Publicado: (2021)

New γ-Halo-δ-lactones and δ-Hydroxy-γ-lactones with Strong Cytotoxic Activity
por: Kamizela, Angelika, et al.
Publicado: (2019)

The human Vδ2(+) T-cell compartment comprises distinct innate-like Vγ9(+) and adaptive Vγ9(-) subsets
por: Davey, Martin S., et al.
Publicado: (2018)

Targeting Mitochondrial Bioenergetics as a Therapeutic Strategy for Chronic Lymphocytic Leukemia
por: Roy Chowdhury, Subir, et al.
Publicado: (2018)

The Role of Phosphoinositide 3-Kinases in Neutrophil Migration in 3D Collagen Gels
por: Martin, Kayleigh J. S., et al.
Publicado: (2015)

Dynamics of the Phosphoinositide 3-Kinase p110δ Interaction with p85α and Membranes Reveals Aspects of Regulation Distinct from p110α
por: Burke, John E., et al.
Publicado: (2011)

Ontogeny of the Immune System: γ/δ and α/β T Cells Migrate from Thymus to the Periphery in Alternating Waves
por: Dunon, D., et al.
Publicado: (1997)

Phosphoinositide 3–kinase γ participates in T cell receptor–induced T cell activation
por: Alcázar, Isabela, et al.
Publicado: (2007)

Noncanonical regulation of insulin-mediated ERK activation by phosphoinositide 3-kinase γ
por: Mohan, Maradumane L., et al.
Publicado: (2017)

Molecular basis for Gβγ-mediated activation of phosphoinositide 3-kinase γ
por: Chen, Chun-Liang, et al.
Publicado: (2023)

Dual inhibition of phosphoinositide 3-kinases delta and gamma reduces chronic B cell activation and autoantibody production in a mouse model of lupus
por: Olayinka-Adefemi, Folayemi, et al.
Publicado: (2023)

Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib
por: Till, Kathleen J., et al.
Publicado: (2023)

Clinical Outcomes in a Large Canadian Centralized CLL Clinic Based on Treatment and Molecular Factors over a Decade
por: Yang, Jiayu, et al.
Publicado: (2023)

Deficiency of p110δ Isoform of the Phosphoinositide 3 Kinase Leads to Enhanced Resistance to Leishmania donovani
por: Khadem, Forough, et al.
Publicado: (2014)

Genetic Defects in Phosphoinositide 3-Kinase δ Influence CD8(+) T Cell Survival, Differentiation, and Function
por: Cannons, Jennifer L., et al.
Publicado: (2018)

Airway epithelial phosphoinositide 3-kinase-δ contributes to the modulation of fungi-induced innate immune response
por: Jeong, Jae Seok, et al.
Publicado: (2018)

Cryptotanshinone Reverses Corticosteroid Insensitivity by Inhibition of Phosphoinositide-3-Kinase-δ in Chronic Obstructive Pulmonary Disease
por: Xie, Tao, et al.
Publicado: (2023)

Two cases of successful sirolimus treatment for patients with activated phosphoinositide 3-kinase δ syndrome 1
por: Jiang, Lu, et al.
Publicado: (2023)

Mitochondrial Respiration Correlates with Prognostic Markers in Chronic Lymphocytic Leukemia and Is Normalized by Ibrutinib Treatment
por: Roy Chowdhury, Subir, et al.
Publicado: (2020)

Frontline Treatment of the Young, Fit Patient with CLL: A Canadian Perspective
por: Costello, Jacqueline, et al.
Publicado: (2021)

Directing leukocyte polarization and migration by the phosphoinositide transfer protein TIPE2
por: Fayngerts, Svetlana A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_69njvu1jn5r504qopam7clhf74